For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $3.25 in the prior trading day, Citius Oncology Inc (NASDAQ: CTOR) closed at $2.82, down -13.23%. In other words, the price has decreased by -$13.23 from its previous closing price. On the day, 0.52 million shares were traded. CTOR stock price reached its highest trading level at $3.185 during the session, while it also had its lowest trading level at $2.82.
Ratios:
Our goal is to gain a better understanding of CTOR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.05 and its Current Ratio is at 0.36. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 27, 2024, initiated with a Buy rating and assigned the stock a target price of $3.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTOR now has a Market Capitalization of 201777760 and an Enterprise Value of 315052960.
Stock Price History:
The Beta on a monthly basis for CTOR is 3.12, which has changed by -0.7530432 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, CTOR has reached a high of $49.00, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 50.74%, while the 200-Day Moving Average is calculated to be 122.99%.
Shares Statistics:
The stock has traded on average 1.15M shares per day over the past 3-months and 1813470 shares per day over the last 10 days, according to various share statistics. A total of 71.55M shares are outstanding, with a floating share count of 3.52M. Insiders hold about 95.08% of the company’s shares, while institutions hold 0.15% stake in the company. Shares short for CTOR as of 1749772800 were 113580 with a Short Ratio of 0.32, compared to 1747267200 on 47100. Therefore, it implies a Short% of Shares Outstanding of 113580 and a Short% of Float of 2.0599999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $72.88M in the next fiscal year. The high estimate is $72.88M and the low estimate is $72.88M.
